Teva Pharmaceuticals USA recalls Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva
Recalled July 23, 2014 · FDA recall D-1436-2014 · Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications: out of specification impurity test results. · FDA Class III
Units
1104 blister packs
Sold at
Nationwide
Description
Failed Impurities/Degradation Specifications: out of specification impurity test results.
Product
Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →